The use of sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: new guidelines hot off the press and directly into guidelines!
Sign Up to like & getrecommendations! Published in 2023 at "Postgraduate medical journal"
DOI: 10.1093/postmj/qgad022
Abstract: It is well known that the prevalence of heart failure (HF) is high and continues to grow. Sodium-glucose cotransporter 2 (SGLT2) inhibitors, although initially developed as a therapy for type 2 diabetes, have been found… read more here.
Keywords: guidelines hot; heart failure; glucose cotransporter; ejection fraction ... See more keywords